Contact this trialFirst, we need to learn more about you.
FGFR Inhibitor
Futibatinib + Pembrolizumab for Bladder Cancer
Recruiting1 awardPhase 2
San Francisco, California
This trial is testing how well a combination of two drugs works in treating patients with urothelial cancer that has spread and cannot be treated with platinum-based drugs.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.